First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
"Our expanding partnerships and innovative solutions position us well for the future."
Moat: SOPHiA GENETICS has a strong moat due to its proprietary technology and extensive genomic database.
growth - Investors are likely attracted to the high growth potential in the precision medicine market.
Interest rates affect SOPHiA GENETICS primarily through the cost of capital for R&D investments.
Watch on earnings: Monthly active users of the SOPHiA DDM platform, Revenue growth rate, Number of partnerships with healthcare providers.
One Sentence Summary:
The bull case is simple: analysts see revenue climbing from $93M to $112M as sophia genetics reported a 30% increase in hospital partnerships in q1 2026, indicating strong demand for its platform.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.